StonvexLoading…
StonvexStonvexStonvexCore line items from MD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $476.20M | $1.91B | $1.42B | $927.20M |
Operating Income | $41.66M | $208.81M | $160.02M | $91.97M |
Net Income | $29.57M | $165.39M | $131.71M | $39.26M |
EPS (Diluted) | $0.36 | $1.94 | $1.54 | $0.70 |
Total Assets | $2.07B | $2.25B | $2.20B | $2.10B |
Total Liabilities | $1.19B | $1.38B | $1.31B | $1.27B |
Cash & Equivalents | $205.78M | $375.24M | $340.06M | $224.73M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 82.06M | 82.98M | 85.83M | 86.85M |